Activity and postantibiotic effect of marbofloxacin, enrofloxacin, difloxacin and ciprofloxacin against feline Bordetella bronchiseptica isolates

被引:19
作者
Carbone, M
Pennisi, MG
Masucci, M
De Sarro, A
Giannone, M
Fera, MT
机构
[1] Policlin Univ, Ist Microbiol, Fac Med & Chirurg, I-98125 Messina, Italy
[2] Univ Messina, Dipartimento Med & Farmacol Vet, Fac Med Vet, I-98125 Messina, Italy
[3] Univ Messina, Fac Med & Chirurg, Ist Farmacol, I-98100 Messina, Italy
关键词
fluoroquinolones; Bordetella bronchiseptica; PAE; cat;
D O I
10.1016/S0378-1135(01)00349-2
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The minimum inhibitory concentration (MIC) and postantibiotic effect (PAE) of marbofloxacin, enrofloxacin, difloxacin and ciprofloxacin were evaluated in vitro against 43 feline-source Bordetella bronchiseptica strains. All strains tested were susceptible to marbofloxacin and enrofloxacin (MIC90 0.5 mg/l), while 93 and 84% of the strains were susceptible, respectively, to ciprofloxacin and difloxacin with MIC90 values of, respectively, 1 and 8 mg/l. The PAE was studied in 10 strains by exposure of bacteria to marbofloxacin. enrofloxacin, difloxacin and ciprofloxacin at 5 and 10 times minimum inhibitory concentration (MIC) for 1 and 2 h. Regrowth was determined by measuring the viable counts after drug removal by a 10(3) dilution procedure. PAEs increased as a function of concentration and exposure time. The mean duration of PAEs varied between 1.1 and 8.2 h, showing the following order: marbofloxacin > enrofloxacin > ciprofloxacin > difloxacin. These data are encouraging since fluoroquinolones have a possible role in the clinical treatment of B. bronchiseptica infections, and the strong PAE caused by quinolones may contribute to the in vivo efficacy of these drugs. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:79 / 84
页数:6
相关论文
共 18 条
[1]   INVITRO ACTIVITY OF THE ARYL-FLUOROQUINOLONES A-56619 AND A-56620 AND EVALUATION OF DISK SUSCEPTIBILITY TESTS [J].
BARRY, AL ;
JONES, RN ;
THORNSBERRY, C ;
AYERS, LW ;
GAVAN, TL ;
GERLACH, EH .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (01) :18-22
[2]   Activity of nine fluoroquinolones against strains of Bordetella bronchiseptica [J].
Carbone, M ;
Fera, MT ;
Pennisi, MG ;
Masucci, M ;
De Sarro, A ;
Macri, C .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1999, 12 (04) :355-358
[3]   POSTANTIBIOTIC EFFECTS IN EXPERIMENTAL-INFECTION MODELS - RELATIONSHIP TO INVITRO PHENOMENA AND TO TREATMENT OF INFECTIONS IN MAN [J].
CRAIG, WA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 :149-158
[4]  
Craig WA, 1996, ANTIBIOTICS LAB MED, P296
[5]   BIOLOGY OF BORDETELLA-BRONCHISEPTICA [J].
GOODNOW, RA .
MICROBIOLOGICAL REVIEWS, 1980, 44 (04) :722-738
[6]   INVITRO EVALUATION OF VARIOUS QUINOLONE ANTIBACTERIAL AGENTS AGAINST VETERINARY MYCOPLASMAS AND PORCINE RESPIRATORY BACTERIAL PATHOGENS [J].
HANNAN, PCT ;
OHANLON, PJ ;
ROGERS, NH .
RESEARCH IN VETERINARY SCIENCE, 1989, 46 (02) :202-211
[7]   ANTIMICROBIAL SUSCEPTIBILITIES OF BORDETELLA SPECIES ISOLATED IN A MULTICENTER PERTUSSIS SURVEILLANCE PROJECT [J].
KURZYNSKI, TA ;
BOEHM, DM ;
ROTTPETRI, JA ;
SCHELL, RF ;
ALLISON, PE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (01) :137-140
[8]  
KUURSTED K, 1987, EUR J CLIN MICROBIOL, V6, P271
[9]   RESPIRATORY-DISEASE IN PIGS - STUDY [J].
LITTLE, TWA .
VETERINARY RECORD, 1975, 96 (25) :540-544
[10]   ANTIMICROBIAL SUSCEPTIBILITY OF BORDETELLA-AVIUM AND BORDETELLA-BRONCHISEPTICA ISOLATES [J].
MORTENSEN, JE ;
BRUMBACH, A ;
SHRYOCK, TR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (05) :771-772